相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TCR Recognition of Peptide-MHC-I: Rule Makers and Breakers
Christopher Szeto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
Krishna Das et al.
NATURE COMMUNICATIONS (2021)
Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
Guodong Liu et al.
PATHOGENS (2021)
T Cell Epitope Predictions
Bjoern Peters et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system
Sinu Paul et al.
PLoS Computational Biology (2020)
MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing
Timothy J. O'Donnell et al.
CELL SYSTEMS (2020)
Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools
Marek Prachar et al.
SCIENTIFIC REPORTS (2020)
The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer
Liesa-Marie Schreiber et al.
BRITISH JOURNAL OF CANCER (2019)
NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions
Bruno Alvarez et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade
Lee P. Richman et al.
CELL SYSTEMS (2019)
The Immune Epitope Database (IEDB): 2018 update
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2019)
Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer
Carles Urbiola et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
Shashi Gujar et al.
TRENDS IN IMMUNOLOGY (2018)
The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
Janine Kimpel et al.
VIRUSES-BASEL (2018)
The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
Ellen Suder et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
Giulia Marelli et al.
FRONTIERS IN IMMUNOLOGY (2018)
Heating it up: Oncolytic viruses make tumors hot' and suitable for checkpoint blockade immunotherapies
Shashi Gujar et al.
ONCOIMMUNOLOGY (2018)
Analysis of CD8+ T cell response during the 2013-2016 Ebola epidemic in West Africa
Saori Sakabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Predicting Antigen Presentation - What Could We Learn From a Million Peptides?
David Gfeller et al.
FRONTIERS IN IMMUNOLOGY (2018)
The immunoproteasome subunit LMP7 is required in the murine thymus for filling up a hole in the Tcell repertoire
Michael Basler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2017)
Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity
Michael Rasmussen et al.
JOURNAL OF IMMUNOLOGY (2016)
Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy
Catherine Dold et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Guidelines for the automated evaluation of Elispot assays
Sylvia Janetzki et al.
NATURE PROTOCOLS (2015)
Measles virus epitope presentation by HLA: novel insights into epitope selection, dominance, and microvariation
Ingrid M. Schellens et al.
FRONTIERS IN IMMUNOLOGY (2015)
Role of peptide processing predictions in T cell epitope identification: contribution of different prediction programs
Jorg J. A. Calis et al.
IMMUNOGENETICS (2015)
Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
Alexander Muik et al.
CANCER RESEARCH (2014)
Understanding and altering cell tropism of vesicular stomatitis virus
Eric Hastie et al.
VIRUS RESEARCH (2013)
The Antiviral Immune Response in Mice Devoid of Immunoproteasome Activity
Michael Basler et al.
JOURNAL OF IMMUNOLOGY (2011)
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Jacques Neefjes et al.
NATURE REVIEWS IMMUNOLOGY (2011)
CD8 T Cell Cross-Reactivity Networks Mediate Heterologous Immunity in Human EBV and Murine Vaccinia Virus Infections
Markus Cornberg et al.
JOURNAL OF IMMUNOLOGY (2010)
Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance
Maya F. Kotturi et al.
JOURNAL OF IMMUNOLOGY (2008)
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Roberto Cattaneo et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent
Elizabeth A. Ramsburg et al.
JOURNAL OF IMMUNOLOGY (2007)
Self-representation in the thymus: An extended view
B Kyewski et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells
AC Karlsson et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Negative selection - Clearing out the bad apples from the T-cell repertoire
E Palmer
NATURE REVIEWS IMMUNOLOGY (2003)
Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: Probing with TCR-like recombinant antibodies
G Denkberg et al.
JOURNAL OF IMMUNOLOGY (2002)
Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus
JN Barr et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory
D Homann et al.
NATURE MEDICINE (2001)
分享论文
